Status:
UNKNOWN
Effect of Zoledronic Acid in Primary Knee Osteoarthritis
Lead Sponsor:
Toufiqe-E-Ealahi
Conditions:
Primary Osteoarthritis
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
We try to find out the effect of zoledronic acid over pain of primary knee osteoarthritis and also functional status in a period of 6 months.
Detailed Description
This will be a double blind placebo controlled randomized clinical trial at department of rheumatology, Bangabandhu Seikh Mujib Medical University (BSMMU) from January 2023 to December 2023. Total 92 ...
Eligibility Criteria
Inclusion
- \>= 50 years
- Knee OA by ACR criteria
- Patient who will be willing to participate in the study
Exclusion
- 1\. Known inflammatory arthritis 2. BMI \>= 40 kg/m2 3. Prior diagnosis of cancer 4. Prior use of bisphosphonates 5. Use of intra articular corticosteroid or hyaluronic acid preparations within 3months 6. Metabolic causes of OA (crystal associated arthritis, acromegaly, wilson's disease, haemachromatosis, Hyperparathyroidism, DM) 7. Mechanical causes of OA (epiphyseal dysplasia, congenital dislocations, limb-length inequality, hypermobility syndromes, avascular necrosis)
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06051344
Start Date
January 1 2023
End Date
December 31 2023
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of rheumatology
Dhaka, Shahbag, Bangladesh, 1000